MicroPort CardioFlow Medtech Corporation

Equities

2160

KYG6082P1054

Medical Equipment, Supplies & Distribution

Delayed Hong Kong S.E. 03:47:29 2024-04-18 am EDT 5-day change 1st Jan Change
0.96 HKD +2.13% Intraday chart for MicroPort CardioFlow Medtech Corporation +1.05% -40.74%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Microport Cardioflow Inks Services Deal with Subsidiary MT
MicroPort CardioFlow Medtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
MicroPort CardioFlow Medtech Corporation Provides Consolidated Revenue Guidance for the Year Ended December 31, 2023 CI
China Approves MicroPort CardioFlow's Application for Atrial Appendage Closure System; Shares Fall 3% MT
Microport Cardioflow Medtech Corporation Receives NMPA Approval for Registration Application of Anchorman LAAC System CI
MicroPort CardioFlow Subsidiary to Buy 51% Stake in Medical Device Maker MT
MicroPort CardioFlow Medtech to Renew Four Agreements With Parent MT
MicroPort's Transcatheter Aortic Heart-Valve Implantation Product Completes Seven Trials in Europe MT
MicroPort CardioFlow Medtech Corporation Completes Clinical Implantation Cases in Europe CI
MicroPort CardioFlow's Transcatheter Aortic Heart Valve Implantation Device Enters Clinical Application Phase MT
MicroPort CardioFlow Medtech Corporation Announces First Two Clinical Applications of Third-Generation TAVI Product CI
Transcript : MicroPort CardioFlow Medtech Corporation, H1 2023 Earnings Call, Aug 31, 2023
MicroPort CardioFlow Medtech Corporation Reports Earnings Results for the Half Year Ended June 30, 2023 CI
MicroPort Cardioflow Medtech Corporation Announces Executive Changes CI
MicroPort Cardioflow Medtech Corporation Announces Executive Changes CI
Microport Cardioflow Medtech Corporation Announces Change of Directors and Chairman,Change in Composition of Board Committees,Change of President and Change of Authorised Representative CI
MicroPort CardioFlow's TMVR System Passes Clinical Trials MT
MicroPort CardioFlow Medtech Corporation Announces Self-Developed TMVR System Achieved Excellent Follow-Up Results in Multiple Clinical Application Cases CI
MicroPort CardioFlow Medtech to Grant 10 Million Share Options MT
MicroPort CardioFlow Medtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
MicroPort CardioFlow Medtech to Widen 2022 Loss MT
MicroPort CardioFlow Medtech Corporation Provides Group Earnings Guidance for the Year Ended December 31, 2022 CI
MicroPort CardioFlow's Products Registered in Thailand MT
MicroPort CardioFlow Medtech Unit Procures Catering, Property Management Services MT
MicroPort CardioFlow Medtech Posts Increase in H1 Loss MT
Chart MicroPort CardioFlow Medtech Corporation
More charts
Microport Cardioflow Medtech Corp is a China-based investment holding company mainly engaged in the medical device industry. The Company is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The Company's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The Company mainly conducts business within the domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.8689 CNY
Average target price
2.412 CNY
Spread / Average Target
+177.62%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2160 Stock
  4. News MicroPort CardioFlow Medtech Corporation
  5. MicroPort CardioFlow Medtech : , Shareholder MicroPort Scientific Team Up for Medical Device Joint Venture